Dolby Laboratories DLB
- Market cap
- $5.4B
- P/E
- 24.6×
Follow DLB
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.38 | 45.13 | 58.17 | 56.09 | 44.68 | 83.10 | 61.55 | 70.26 | 66.35 | 64.02 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 55.02 | 63.34 | 74.29 | 70.17 | 97.50 | 104.74 | 96.85 | 91.02 | 86.37 | 89.66 |
High Price
|
|||
| 2,030 | 2,122 | 2,151 | 2,193 | 2,289 | 2,368 | 2,336 | 2,246 | 2,080 | 2,051 |
Employees
|
|||
| 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Revenue/Emp
|
|||
| 1,026 | 1,080 | 1,055 | 1,242 | 1,162 | 1,281 | 1,254 | 1,300 | 1,274 | 1,349 |
Revenue
|
|||
| 89.38% | 89.03% | 87.90% | 87.04% | 87.39% | 89.85% | 88.73% | 88.26% | 88.97% | 88.13% |
Gross Margin
|
|||
| 236 | 255 | 196 | 282 | 240 | 355 | 215 | 250 | 312 | 303 |
EBT
|
|||
| 23.00% | 23.62% | 18.62% | 22.74% | 20.63% | 27.67% | 17.17% | 19.24% | 24.53% | 22.49% |
EBT Margin
|
|||
| 186 | 207 | 42 | 256 | 232 | 318 | 184 | 202 | 264 | 256 |
Net Income
|
|||
| 89 | 87 | 84 | 85 | 113 | 114 | 105 | 95 | 84 | 99 |
Depreciation
|
|||
| 10.18 | 10.61 | 10.20 | 12.22 | 11.55 | 12.66 | 12.54 | 13.57 | 13.33 | 14.07 |
Revenue/Sh
|
|||
| 1.85 | 1.98 | 0.41 | 2.51 | 2.30 | 3.07 | 1.84 | 2.10 | 2.74 | 2.66 |
Earnings/Sh
|
|||
| 3.58 | 3.71 | 3.41 | 3.22 | 3.42 | 4.42 | 3.19 | 3.83 | 3.43 | 4.93 |
Cash Flow/Sh
|
|||
| (2.20) | (1.03) | (0.83) | (1.12) | (0.69) | (0.38) | (0.59) | (0.32) | (0.31) | (0.44) |
Capex/Sh
|
|||
| 1.37 | 2.68 | 2.58 | 2.11 | 2.73 | 4.05 | 2.59 | 3.52 | 3.11 | 4.49 |
Free CF/Sh
|
|||
| 19.65 | 21.06 | 22.93 | 22.76 | 24.25 | 25.74 | 22.51 | 24.77 | 26.03 | 27.45 |
Book Value/Sh
|
|||
| 101 | 102 | 103 | 102 | 101 | 101 | 100 | 96 | 96 | 96 |
Shares
|
|||
| 29.35 | 29.08 | 150.83 | 25.75 | 28.69 | 28.66 | 35.41 | 38.43 | 28.03 | 27.21 |
PE Ratio
|
|||
| 5.33 | 5.45 | 6.79 | 5.29 | 5.74 | 6.95 | 5.20 | 5.95 | 5.74 | 5.14 |
PS Ratio
|
|||
| 2.76 | 2.75 | 3.02 | 2.84 | 2.73 | 3.42 | 2.89 | 3.26 | 2.94 | 2.64 |
PB Ratio
|
|||
| 4.71 | 4.64 | 5.75 | 4.55 | 4.77 | 5.96 | 4.54 | 5.21 | 5.29 | 4.55 |
EV/Sales
|
|||
| 34.90 | 18.35 | 22.71 | 26.36 | 20.15 | 18.75 | 21.99 | 20.82 | 23.57 | 14.28 |
EV/FCF
|
|||
| 360 | 378 | 352 | 328 | 344 | 448 | 319 | 367 | 327 | 472 |
Op' Cash Flow
|
|||
| (222) | (105) | (85) | (114) | (69) | (38) | (59) | (30) | (30) | (42) |
Capex
|
|||
| 138 | 273 | 267 | 214 | 275 | 410 | 259 | 337 | 297 | 430 |
FCF
|
|||
| 547 | 766 | 1,211 | 1,075 | 1,280 | 1,445 | 1,033 | 1,066 | 777 | 950 |
Working Cap'
|
|||
| — | — | — | — | 81 | 72 | 51 | 51 | — | — |
Total Debt
|
|||
| (641) | (882) | (1,103) | (925) | (1,127) | (1,272) | (818) | (957) | (578) | (794) |
Net Debt
|
|||
| 1,979 | 2,144 | 2,371 | 2,313 | 2,438 | 2,604 | 2,251 | 2,372 | 2,487 | 2,632 |
Sh' Equity
|
|||
| 8.37% | 8.53% | 1.55% | 8.97% | 8.06% | 10.30% | 6.35% | 7.08% | 8.60% | 8.05% |
ROA
|
|||
| 10.83% | 12.24% | 9.05% | 11.57% | 10.42% | 16.16% | 9.01% | 9.53% | 8.46% | 9.01% |
ROIC
|
|||
| 9.80% | 10.02% | 1.85% | 10.90% | 9.74% | 12.30% | 7.58% | 8.68% | 10.78% | 9.96% |
ROE
|
|||
Dolby Laboratories peers in Specialty Business Services
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| AMTM Amentum Holdings, Inc. | $4.8B | 23.1× | Compare |
| UNF Unifirst Corporation | $4.5B | 39.1× | Compare |
| AZZ AZZ Inc. | $4.2B | 20.8× | Compare |
| FA First Advantage Corporation | $3.4B | 135× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| CBZ CBIZ, Inc. | $3.0B | 25.6× | Compare |
| ABM ABM Industries Incorporated | $2.9B | 17.9× | Compare |
| RTO Rentokil Initial PLC | $10.3B | 60.5× | Compare |
| MMS Maximus, Inc. | $2.8B | 7.7× | Compare |
Dolby Laboratories (DLB) key facts
- Dolby Laboratories (DLB) is a Specialty Business Services company in the Industrials sector, listed on the New York Stock Exchange.
- Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.
- Net income was $256.5 million, or $2.66 per share (basic), a net margin of 18.9%.
- As of September 25, 2026, DLB traded at $58.56, a market capitalization of $5.4 billion.
- At that price the stock trades at 24.6× trailing-twelve-month earnings and 4.1× sales.
- Dolby Laboratories pays an annual dividend of $1.08 per share, a yield of 1.38%, with a payout ratio of 47.1%.
- Return on equity was 9.96% and debt-to-equity 0.00.
Dolby Laboratories (DLB) Latest News
25 Sep
Dolby Laboratories (DLB) returns to investor focus as Meta extends Dolby Atmos and Dolby Vision across Meta AI glasses, Instagram, and a future VR headset, widening Dolby’s role in consumer hardware and social platforms. Shares have weakened, with 30-day return -12.95%, YTD -9.4%, and 1-year TSR -17.52%. The piece urges scanning for similar partnerships across other audio/video platforms, listing 16 undiscovered gems. Analysts see upside from usage-based licensing and higher-margin formats, with a fair value around $79 vs. $57.56 today. Growth in Atmos, Vision, and imaging patents could lift licensing revenue ~15% YoY and near half of licensing revenue by FY26, helping margins. Risks include higher component costs for low-end devices and content or automotive royalties not scaling as modeled. Investors are asked to weigh four rewards against one warning sign. Expansion of cross-platform Meta deal could meaningfully boost Dolby's licensing revenue and margins.
24 Sep
Meta and Dolby Laboratories announced that Meta AI glasses will capture audio in Dolby Atmos and expand Dolby Vision experiences across Instagram and Meta’s upcoming VR headset, deepening Dolby’s role in social, AR, and VR media. The move broadens Dolby’s formats beyond cinema and home entertainment into everyday content creation and sharing inside one of the world’s largest consumer ecosystems. Dolby’s investment narrative now hinges on continued relevance of premium audio and video formats as media shifts to streaming and immersive platforms. While the deal strengthens Dolby’s footprint via Meta, near-term concerns remain about muted revenue growth and margin pressure. Dolby OptiView’s updates—adding Dolby Vision and AI-powered Sports Intelligence—plus the Meta tie-in represent potential growth vectors, but their ability to offset rising expenses and weaker legacy licensing momentum is still uncertain. Projections imply moderate growth to 2029 with upside if adoption scales. Expansion into Meta's social/AR/VR ecosystem could meaningfully expand Dolby's addressable market beyond cinema, potentially altering growth trajectory.
Dolby Laboratories expands Atmos and Dolby Vision across Meta Platforms' ecosystem, extending the tech to Meta AI glasses, Instagram and Meta's forthcoming VR devices. Meta AI glasses will be capable of capturing Dolby Atmos audio for Instagram moments, while Dolby Vision remains available on Instagram and other platforms. The expansion also broadens support to new device categories, including smart glasses and video cameras, and Meta’s next VR device will launch with Dolby Vision and Dolby Atmos. Dolby says Atmos, Vision and imaging-patent revenue could rise about 15% year over year in fiscal 2026, boosted by wider adoption. Meta became a licensee of Dolby’s video distribution patent program, with about 45 licensors in its first year. Competitors cited include Sony and Sonos, underscoring Dolby’s expanding reach in consumer devices and content experiences. Deepens Dolby's consumer-device ecosystem and revenue potential by integrating Atmos/Vision across Meta's popular platforms and upcoming devices.
Dolby Laboratories (DLB) and Meta Platforms (META) said they’re expanding Dolby Atmos and Dolby Vision throughout Meta’s ecosystem. Meta’s new AI glasses will be the first global consumer device capable of capturing audio in Dolby Atmos, enabling spatial audio recording and sharing on Instagram, which already supports Dolby Vision. The effort builds on Instagram’s Dolby Vision rollout last year and extends Dolby’s presence across Meta’s social, wearable, and VR platforms. Meta also said its upcoming VR device will support Dolby Vision and Dolby Atmos at launch next year, in tandem with Connect 2026’s unveiling of a $1,299 VR glasses device and a broader Muse AI rollout. Dolby’s collaboration with Meta could boost Dolby Atmos/Vision adoption across consumer devices and experiences, potentially benefiting Dolby’s licensing revenue and product penetration. Expanding Atmos/Vision across Meta devices creates a meaningful growth opportunity for Dolby's licensing and adoption.
September 2026 sees EssilorLuxottica, Meta, and Dolby broaden Meta's wearables ecosystem with over 100 Ray-Ban Meta AI and Audio styles, adding Dolby Atmos capture and Dolby Vision/Atmos support to Instagram and a forthcoming VR device. Muse, Meta's personal AI agent, runs on these AI glasses, turning eyewear into a hands-free compute interface that links AI, commerce, and entertainment to Meta's hardware footprint. Near-term revenues hinge on Muse uptake, while heavy AI capex for Reality Labs remains the main margin and free-cash-flow risk. The Dolby–Ray-Ban collaboration expands Atmos-enabled glasses but doesn't fundamentally alter the risk-reward balance in the near term. If adoption accelerates, it could bolster Muse-focused commerce and expand Dolby's wearables revenue, though AI capex and regulation keep upside constrained. Expands Dolby's exposure to AR wearables and AI-enabled ecosystems, offering potential revenue lift but not resolving margin pressures.
23 Sep
Dolby Laboratories and Meta expand Dolby Atmos and Dolby Vision across Meta's ecosystem, enabling new experiences on Meta AI glasses, Instagram, and future VR devices. Meta AI glasses will be the first global consumer device capable of capturing audio in Dolby Atmos, letting users capture moments and share them on Instagram with enhanced immersion. Dolby Vision has already expanded to Instagram; Atmos and Vision will now span more Meta platforms. Meta's upcoming VR device will support Dolby Vision and Dolby Atmos, delivering more immersive movies, shows, sports, concerts, and premium VR experiences when it launches next year. Dolby says the goal is deeper emotional engagement across creation, sharing, and consumption. Expansion into Meta's vast consumer ecosystem could meaningfully boost Dolby's licensing revenue and adoption of Atmos/Vision.
15 Sep
Rising component costs and weak consumer spending threaten Dolby Laboratories' growth outlook. Rising component costs and weak consumer spending may pressure Dolby Laboratories financial performance.
10 Sep
Dolby Laboratories expands Dolby OptiView Platform with new capabilities announced at IBC 2026. Platform expansion adds new capabilities that support product innovation and may moderately affect competitive positioning.
27 Aug
Dolby Laboratories expands into in-car gaming and live sports streaming. Strategic expansion into in-car gaming and live sports streaming constitutes major move likely to alter company trajectory.
11 Aug
Dolby Laboratories acquired FAU video compression technology portfolio. Acquisition adds video compression technology to Dolby's portfolio.
8 Aug
Dolby Laboratories encounters a billion dollar setback that highlights major risks for investors in the company's operations and outlook. Billion dollar scale events signal major financial or strategic shifts likely to alter the company's trajectory.
6 Aug
Dolby Vision 2 launches on Hisense TVs as Dolby's most advanced picture technology. Hisense TV rollout expands Dolby Vision 2 adoption and strengthens core AV technology positioning.
3 Aug
Dolby Laboratories questions whether its fiscal Q4 growth outlook can overcome licensing volatility. Licensing volatility creates moderate risk to Dolby revenue stability and growth outlook.
Dolby Laboratories stock faces scrutiny over growth potential clashing with near-term execution risks that could affect buying decisions and performance outlook. Growth versus execution risks point to moderate effects on financial performance and investor sentiment without major trajectory shifts.
1 Aug
Dolby Laboratories raised buybacks and guidance. Stock rose 18 percent. Bull case for the company now under review after the updates. Raising buybacks and guidance constitutes major strategic moves that could significantly alter the company's trajectory and investor sentiment.
Dolby Laboratories Q3 results prompt assessment of whether stock appears fairly valued based on performance and market conditions. Q3 earnings and valuation review may moderately influence financial sentiment and short-term positioning but lack transformative elements.
31 Jul
Dolby Laboratories Inc reported strong licensing growth in its Q3 2026 earnings call. Strong licensing growth signals expanded revenue potential that can materially lift future results.
Dolby Laboratories Q2 results show patent licensing and automotive momentum offsetting softer device sales. Patent licensing and automotive momentum balance device sales weakness with moderate effect on future performance.
Dolby Laboratories Q3 earnings call highlighted financial results, licensing revenue trends, product adoption for Atmos and Vision, and forward guidance on partnerships and technology expansion. Q3 earnings call supplies updated financial metrics and strategic outlook that may shift near-term market sentiment without fundamentally redirecting long-term trajectory.
30 Jul
Dolby Laboratories, Inc. held its Q3 2026 earnings call covering quarterly financial results, business performance, and forward outlook. Quarterly earnings details and guidance can moderately shift investor sentiment and short-term valuation.
Dolby Laboratories held its Q3 2026 earnings call covering quarterly financial results, business performance, and forward outlook. Earnings call supplies quarterly financial metrics and strategy details that may shift near-term investor sentiment.
Dolby Laboratories reported Q3 earnings along with analysis of key metrics. Q3 earnings and metrics offer moderate insight into financial performance and investor sentiment.
Dolby Laboratories missed Q2 CY2026 sales expectations. Missing quarterly sales targets typically triggers short-term negative stock reactions and reduced investor sentiment.
Dolby Laboratories reported its third quarter 2026 financial results. Quarterly earnings releases typically drive moderate short-term shifts in valuation and sentiment.
16 Jul
Sony's entertainment strategy raises questions about supporting long-term growth, with potential effects on Dolby Laboratories' technology partnerships and market position in audio-visual entertainment. Sony strategy shifts may moderately influence Dolby revenue and competitive positioning in entertainment.
11 Jun
Dolby Laboratories secures World Cup deal underscoring its expanding role in premium streaming standards. World Cup partnership strengthens Dolby's streaming standards position with major visibility.
29 May
Dolby partners with rednote to integrate Dolby Atmos into video content for enhanced immersive storytelling. Partnership expands Dolby Atmos adoption in video production with moderate effect on innovation and positioning.
4 May
Dolby Laboratories (DLB) released Q3 2025 earnings call transcript detailing financial results, revenue growth, profitability, and strategic updates on audio, imaging, and licensing segments. Q3 2025 earnings transcript discloses financial performance and guidance that significantly influence DLB's valuation and investor outlook.
Dolby Laboratories beat Q2 earnings estimates with mixed results but issued softer forward guidance, prompting a valuation reassessment amid concerns over future growth. Mixed Q2 beat tempered by softer guidance will moderately affect financial performance and investor sentiment without fundamentally altering long-term trajectory.
3 May
Dolby Laboratories' Q1 results show mixed guidance, with an expanding ecosystem shaping the company's future outlook. Mixed Q1 guidance offsets ecosystem expansion, creating moderate influence on financial performance and investor sentiment.